Featured News

01/13/2021

Chinese IPO Qilian Doubles in U.S. Trading Debut

Two Chinese initial public offerings opened for trading Tuesday, with Qilian International Holding Group making a powe...

02/24/2020

AnPac Bio-Medical Science Co., Ltd’s $16 Million Initial Public Offering

Cleary Gottlieb Steen & Hamilton LLP acted as counsel to the Company, and Sheppard Mullin Richter & Hampton LLP ...

11/15/2019

Chinese cancer diagnostics provider AnPac Bio-Medical Science sets terms for $22 million US IPO

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday....

UNIVEST SECURITIES IN THE NEWS

12/10/2024

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

New York, Dec. 10, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in […]

12/06/2024

Univest Securities, LLC Announces Closing of $9.5 Million Public Offering for its Client Algorhythm Holdings, Inc. (NASDAQ: RIME)

New York, Dec. 06, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of public offering (the “Offering”) of approximately $9.5 million for its client Algorhythm Holdings, Inc. (NASDAQ: RIME) (the “Company”), an […]

11/25/2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

New York, Nov. 25, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of private placement of 5,100 Series A-2 Preferred Shares, with a stated value of US$1,000 per share, for its client […]

11/19/2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (“Qualigen” or the “Company”), Qualigen Therapeutics, Inc., is a life science company focused on developing platform treatments for adult and pediatric cancers, with the potential for orphan drug designations, announced today that it has entered into definitive securities purchase agreements with several institutional and […]